Further investigation is required to elucidate whether dysregulation of other signaling pathways which cross talk with the TGF-β signaling pathway could serve as the second hits in the pathogenesis of HHT. The gene discussed is TGFB1; the disease is hereditary hemorrhagic telangiectasia.